A Characterization of Central Auditory Processing in Parkinson's Disease.

Mexico Parkinson’s disease Psychometrics auditory processing cognition digital assessment hearing non-motor symptoms

Journal

Journal of Parkinson's disease
ISSN: 1877-718X
Titre abrégé: J Parkinsons Dis
Pays: Netherlands
ID NLM: 101567362

Informations de publication

Date de publication:
15 Jul 2024
Historique:
medline: 20 7 2024
pubmed: 20 7 2024
entrez: 20 7 2024
Statut: aheadofprint

Résumé

Research indicates that people with Parkinson's disease (PwPs) may experience challenges in both peripheral and central auditory processing, although findings are inconsistent across studies. Due to the diversity of auditory measures used, there is a need for standardized, replicable hearing assessments to clarify which aspects of audition are impacted in PWPs and whether they are linked to motor and non-motor symptoms. To characterize auditory processes and their possible alteration in PwPs. To address this, we collected a comprehensive set of standardized measures of audition using PART, a digital testing platform designed to facilitate replication. Additionally, we examined the relationship between auditory, cognitive, and clinical variables in PwPs. We included 44 PwPs and 54 age and education matched healthy controls. Assessments included detection of diotic and dichotic frequency modulation, temporal gaps, spectro-temporal broad-band modulation, and speech-on-speech masking. We found no statistically significant differences in auditory processing measures between PwPs and the comparison group (ps >  0.07). In PwPs, an auditory processing composite score showed significant medium size correlations with cognitive measures (0.39 <  r<0.41, ps <  0.02) and clinical variables of motor symptom severity, quality of life, depression, and caretaker burden (0.33 <  r<0.52, ps <  0.03). While larger datasets are needed to clarify whether PwPs experience more auditory difficulties than healthy controls, our results underscore the importance of considering auditory processing on the symptomatic spectrum of Parkinson's disease using standardized replicable methodologies. It is unknown whether there exists a relationship between Parkinson’s disease (PD) and hearing ability. While some studies have found hearing difficulties to be associated with PD, other studies failed to replicate these effects. We suggest that a possible reason for these differing findings are differences in how hearing is measured. To clarify the literature, we tested a group of people with Parkinson’s (PwPs) on several aspects of hearing using a freely available tablet-based app. We compared PwPs hearing tests to those of an age and education matched group of people without PD. While we found no clear differences among the groups, we did find better hearing abilities were related to less motor symptom severity and depression, better reported quality of life, and less reported burden of the disease experienced by the caretaker. We conclude that while there is no solid evidence showing the hearing is necessarily impaired in PD, that measuring hearing in PwPs can provide valuable clinical information. This can inform new approaches to treatment for people living with PD such as those related with improving hearing.

Sections du résumé

Background UNASSIGNED
Research indicates that people with Parkinson's disease (PwPs) may experience challenges in both peripheral and central auditory processing, although findings are inconsistent across studies. Due to the diversity of auditory measures used, there is a need for standardized, replicable hearing assessments to clarify which aspects of audition are impacted in PWPs and whether they are linked to motor and non-motor symptoms.
Objective UNASSIGNED
To characterize auditory processes and their possible alteration in PwPs. To address this, we collected a comprehensive set of standardized measures of audition using PART, a digital testing platform designed to facilitate replication. Additionally, we examined the relationship between auditory, cognitive, and clinical variables in PwPs.
Methods UNASSIGNED
We included 44 PwPs and 54 age and education matched healthy controls. Assessments included detection of diotic and dichotic frequency modulation, temporal gaps, spectro-temporal broad-band modulation, and speech-on-speech masking.
Results UNASSIGNED
We found no statistically significant differences in auditory processing measures between PwPs and the comparison group (ps >  0.07). In PwPs, an auditory processing composite score showed significant medium size correlations with cognitive measures (0.39 <  r<0.41, ps <  0.02) and clinical variables of motor symptom severity, quality of life, depression, and caretaker burden (0.33 <  r<0.52, ps <  0.03).
Conclusions UNASSIGNED
While larger datasets are needed to clarify whether PwPs experience more auditory difficulties than healthy controls, our results underscore the importance of considering auditory processing on the symptomatic spectrum of Parkinson's disease using standardized replicable methodologies.
It is unknown whether there exists a relationship between Parkinson’s disease (PD) and hearing ability. While some studies have found hearing difficulties to be associated with PD, other studies failed to replicate these effects. We suggest that a possible reason for these differing findings are differences in how hearing is measured. To clarify the literature, we tested a group of people with Parkinson’s (PwPs) on several aspects of hearing using a freely available tablet-based app. We compared PwPs hearing tests to those of an age and education matched group of people without PD. While we found no clear differences among the groups, we did find better hearing abilities were related to less motor symptom severity and depression, better reported quality of life, and less reported burden of the disease experienced by the caretaker. We conclude that while there is no solid evidence showing the hearing is necessarily impaired in PD, that measuring hearing in PwPs can provide valuable clinical information. This can inform new approaches to treatment for people living with PD such as those related with improving hearing.

Autres résumés

Type: plain-language-summary (eng)
It is unknown whether there exists a relationship between Parkinson’s disease (PD) and hearing ability. While some studies have found hearing difficulties to be associated with PD, other studies failed to replicate these effects. We suggest that a possible reason for these differing findings are differences in how hearing is measured. To clarify the literature, we tested a group of people with Parkinson’s (PwPs) on several aspects of hearing using a freely available tablet-based app. We compared PwPs hearing tests to those of an age and education matched group of people without PD. While we found no clear differences among the groups, we did find better hearing abilities were related to less motor symptom severity and depression, better reported quality of life, and less reported burden of the disease experienced by the caretaker. We conclude that while there is no solid evidence showing the hearing is necessarily impaired in PD, that measuring hearing in PwPs can provide valuable clinical information. This can inform new approaches to treatment for people living with PD such as those related with improving hearing.

Identifiants

pubmed: 39031381
pii: JPD230458
doi: 10.3233/JPD-230458
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

E Sebastian Lelo de Larrea-Mancera (ES)

Department of Psychology, Northeastern University, Boston, MA, USA.
Laboratory of Cognitive and Clinical Neurophysiology, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez (INNNMVS), México.

Erick I Correa-Medina (EI)

Laboratory of Cognitive and Clinical Neurophysiology, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez (INNNMVS), México.
Faculty of Psychology, Universidad Nacional AutÓnoma de México (UNAM), México.

Katia Padilla-Bustos (K)

Laboratory of Cognitive and Clinical Neurophysiology, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez (INNNMVS), México.
Faculty of Psychology, Universidad Nacional AutÓnoma de México (UNAM), México.

Diana Paulina Romero Terán (DP)

Laboratory of Cognitive and Clinical Neurophysiology, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez (INNNMVS), México.

Ana Jimena Hernández-Medrano (AJ)

Clinical Laboratory of Neurodegenerative Diseases, INNNMVS, México.
Data Science Program, University of Maryland, Baltimore, MD, USA.

Gloria Itzel Cerda-Hernández (GI)

Clinical Laboratory of Neurodegenerative Diseases, INNNMVS, México.

Amin Cervantes-Arriaga (A)

Clinical Laboratory of Neurodegenerative Diseases, INNNMVS, México.

Mayela Rodríguez-Violante (M)

Clinical Laboratory of Neurodegenerative Diseases, INNNMVS, México.

Frederick J Gallun (FJ)

Department of Otolaryngology, Oregon Health & Science University, Portland, OR, USA.

Aaron R Seitz (AR)

Department of Psychology, Northeastern University, Boston, MA, USA.

Rodolfo Solís-Vivanco (R)

Laboratory of Cognitive and Clinical Neurophysiology, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez (INNNMVS), México.
Faculty of Psychology, Universidad Nacional AutÓnoma de México (UNAM), México.

Classifications MeSH